(Total Views: 239)
Posted On: 02/08/2018 4:17:28 PM
Post# of 72446
Here's another reply to A17.
sox040713 Thursday, 02/08/18 04:12:49 PM
Re: Amatuer17 post# 216351
Post #216527 of 216527
Only here it's a negative when management takes a 50% pay cut and operating cost / dilution reduces as a result. Maybe Dr. Menon is working part-time now? Talk about twisting words.
Of course success isn't given in drug development. MOA was observed (primary endpoint met) in the first cohort so IPIX decided to save money and focus on oral formulation. Here's a proof of p53 modulation.
Yes you can ask questions. I've contacted Leo by phone and email before. You can also write your comments here.
http://www.ipharminc.com/contact-us
sox040713 Thursday, 02/08/18 04:12:49 PM
Re: Amatuer17 post# 216351
Post #216527 of 216527
Only here it's a negative when management takes a 50% pay cut and operating cost / dilution reduces as a result. Maybe Dr. Menon is working part-time now? Talk about twisting words.
Of course success isn't given in drug development. MOA was observed (primary endpoint met) in the first cohort so IPIX decided to save money and focus on oral formulation. Here's a proof of p53 modulation.
Yes you can ask questions. I've contacted Leo by phone and email before. You can also write your comments here.
http://www.ipharminc.com/contact-us
(3)
(0)
